Targeting Histone Deacetylases in Diseases: Where Are We?
about
Pancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageHDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escapeChemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.PCI-24781 can improve in vitro and in vivo developmental capacity of pig somatic cell nuclear transfer embryos.ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001.Epigenetic control of the tumor microenvironment.Histone Deacetylase 2 Is a Component of Influenza A Virus-Induced Host Antiviral Response.Real-time visualization of chromatin modification in isolated nuclei.Chromatin remodeling modulates radiosensitivity of the daughter cells derived from cell population exposed to low- and high-LET irradiation.Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses.Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases.Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.Combined HAT/EZH2 modulation leads to cancer-selective cell death.Histone deacetylases in hearing loss: Current perspectives for therapy.Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles
P2860
Q28079735-E637407A-3066-426D-ABBD-EEC0A651BA8DQ35176173-AEDC8076-E1CB-4451-9C86-755FF804B573Q35928052-1ECE8479-8044-46FA-B0D8-34BF1122F856Q36043500-FD989BA4-E2A0-4A29-A07D-F9B954D5BFEFQ36213571-98512A58-C750-4A9F-A6A5-F850895A9F2AQ38950582-71C347A4-AEB0-4365-9A7C-E703AC5E7364Q38971785-0F9A5630-434F-4F61-AAFD-3E13C8782BBCQ40097305-A612A026-6253-409A-83E4-081676782AEAQ40108650-41880DF4-1770-4C49-962E-B251D1945968Q41592921-6EE21D5C-6042-4963-9A51-F851C7986B36Q41718442-A0CCE0DD-FFDC-4FF2-9BD2-8574343CC71AQ41739570-204E83DC-474F-42FD-B5D6-0425C0415FC6Q42647696-BF958E8B-E283-47B0-BD35-49A3A6DC5105Q47140442-3376B95F-EFD1-490C-AE30-8C7FFB50B79BQ48237579-D9DEDD26-AEBD-4A38-BC7B-A5B896B1232BQ55093017-044D3225-5F91-4E2B-AC82-10D4F261A400Q55475017-29DA0722-FFC8-4AE5-8B5E-2AE234933D63Q57170401-A75BFAFC-3211-4401-9F3D-8791E2D20D09
P2860
Targeting Histone Deacetylases in Diseases: Where Are We?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting Histone Deacetylases in Diseases: Where Are We?
@ast
Targeting Histone Deacetylases in Diseases: Where Are We?
@en
type
label
Targeting Histone Deacetylases in Diseases: Where Are We?
@ast
Targeting Histone Deacetylases in Diseases: Where Are We?
@en
prefLabel
Targeting Histone Deacetylases in Diseases: Where Are We?
@ast
Targeting Histone Deacetylases in Diseases: Where Are We?
@en
P2860
P50
P356
P1476
Targeting Histone Deacetylases in Diseases: Where Are We?
@en
P2860
P304
P356
10.1089/ARS.2013.5776
P577
2014-03-06T00:00:00Z